Cell and gene therapies could prove disruptive in terms of the life-changing benefits they could bring to people with rare diseases and cancers – but they could also mean healthcare systems
Spectral AI is on the brink of becoming a commercial-stage company, with the first sales of its DeepView wound imaging system due to start in its first market, the UK, lat
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.